ACCENTIA BIOPHARMACEUTICALS INC

Delisted

CIK 1310094fmd_1KNZQYKW8VZ7AN0T21K6646JFXManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Oct 01, 2009 to Sep 30, 2012, 10 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).